These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15030338)

  • 1. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
    Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
    Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
    Ruiz A; Puig S; Malvehy J; Lázaro C; Lynch M; Gimenez-Arnau AM; Puig L; Sánchez-Conejo J; Estivill X; Castel T
    J Med Genet; 1999 Jun; 36(6):490-3. PubMed ID: 10874641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the CDKN2A locus in patients with multiple primary melanomas.
    Puig S; Malvehy J; Badenas C; Ruiz A; Jimenez D; Cuellar F; Azon A; Gonzàlez U; Castel T; Campoy A; Herrero J; Martí R; Brunet-Vidal J; Milà M
    J Clin Oncol; 2005 May; 23(13):3043-51. PubMed ID: 15860862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
    Begg CB; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Mitra N; Busam K; From L; Berwick M;
    J Natl Cancer Inst; 2005 Oct; 97(20):1507-15. PubMed ID: 16234564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of mutations in the p16/CDKN2A gene in sporadic and familial melanoma in the Polish population.
    Lamperska K; Karezewska A; Kwiatkowska E; Mackiewicz A
    Acta Biochim Pol; 2002; 49(2):369-76. PubMed ID: 12362978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
    Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
    J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between familial and nonfamilial melanoma in France.
    Grange F; Chompret A; Guilloud-Bataille M; Guillaume JC; Margulis A; Prade M; Demenais F; Avril MF
    Arch Dermatol; 1995 Oct; 131(10):1154-9. PubMed ID: 7574832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study on the familial aggregation of cutaneous malignant melanoma in Iceland.
    Eldon BJ; Thorlacius S; Jonsson T; Jonasson JG; Kjartansson J; Bodvarsson S; Steingrimsson E; Rafnar T
    Eur J Cancer; 2006 May; 42(7):922-6. PubMed ID: 16530404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy.
    Casula M; Colombino M; Satta MP; Cossu A; Lissia A; Budroni M; Simeone E; Calemma R; Loddo C; Caracò C; Mozzillo N; Daponte A; Comella G; Canzanella S; Guida M; Castello G; Ascierto PA; Palmieri G;
    Eur J Cancer; 2007 Jan; 43(1):137-43. PubMed ID: 17055252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
    Berwick M; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Busam K; From L; Mujumdar U; Wilcox H; Begg CB;
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1520-5. PubMed ID: 16896043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple primary melanoma revisited.
    Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
    Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmed cancer trends in families of patients with multiple cancers including cutaneous melanoma.
    Nielsen K; Masback A; Bladstrom A; Lundgren L; Jonsson N; Borg A; Ingvar C; Olsson H
    Br J Dermatol; 2008 Feb; 158(2):429-31. PubMed ID: 18047508
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
    Lasithiotakis K; Leiter U; Krüger-Krasagakis S; Tosca A; Garbe C
    Br J Dermatol; 2006 Jun; 154(6):1123-7. PubMed ID: 16704644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
    van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
    J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-genetic aspects of cutaneous melanoma. II. Interconnection and pathogenetic commonality with dysplastic nevus syndrome].
    Kharkevich GIu; Kazubskaia TP; Agapova RK; Musatov VK; Trubnikov VI; Demidov LV; Gar'kavtseva RF
    Genetika; 1995 Nov; 31(11):1562-5. PubMed ID: 8666223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
    Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
    Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales.
    Giles G; Staples M; McCredie M; Coates M
    Melanoma Res; 1995 Dec; 5(6):433-8. PubMed ID: 8589618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
    Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
    Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma.
    Majore S; De Simone P; Crisi A; Eibenschutz L; Binni F; Antigoni I; De Bernardo C; Catricalà C; Grammatico P
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):209-11. PubMed ID: 18363633
    [No Abstract]   [Full Text] [Related]  

  • 20. High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families.
    Hocevar M; Avbelj M; Perić B; Zgajnar J; Besić N; Battelino T
    Croat Med J; 2006 Dec; 47(6):851-4. PubMed ID: 17167857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.